Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 May;19(3):344-354.
doi: 10.1016/j.jcf.2020.02.015. Epub 2020 Feb 27.

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease

Affiliations
Free article
Practice Guideline

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease

Siddhartha G Kapnadak et al. J Cyst Fibros. 2020 May.
Free article

Abstract

Background: Advanced cystic fibrosis lung disease (ACFLD) is common, is associated with reduced quality of life, and remains the most frequent cause of death in individuals with cystic fibrosis (CF). These consensus guidelines provide recommendations to the CF community on management of both common and unique issues that arise when individuals reach a state of ACFLD.

Methods: The CF Foundation assembled a multidisciplinary expert panel consisting of three workgroups: Pulmonary management; Management of comorbid conditions; Symptom management and psychosocial issues. Topics were excluded if the management considerations did not differ in ACFLD from in the overall CF population or if already addressed in other published guidelines. Recommendations were based on a systematic literature review combined with expert opinion when appropriate.

Results: The committee formulated twenty-three recommendation statements specific to ACFLD that address the definition of ACFLD, pulmonary and intensive care unit management, management of selected comorbidities, symptom control, and psychosocial issues.

Conclusions: These recommendations are intended to be paired with previously published management guidelines for the overall CF population, with the objective of reducing practice variability and improving overall care, quality of life, and survival in those with ACFLD.

Keywords: Advance care planning; Advanced lung disease; Cystic fibrosis; Lung transplantation; Palliative care; Respiratory failure.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest BM reports grants and other support from Medtronic and Ironwood Pharmaceuticals (outside of the submitted work). DH reports grants from the Cystic Fibrosis Foundation (Mental Health Coordinator, Physical Therapy and Pharmacist grant) and Astra Zeneca Advisory Board (outside of the submitted work) DY reports grants from the Cystic Fibrosis Foundation and personal fees from Gilead Sciences Advisory Committee, Vertex Pharmaceuticals Advisory Committee, Academy of Managed Care Pharmacy, Pharmacy Times Continuing Education, and ProCE (outside of the submitted work). EPD, JMP, and LGS report grants from Cystic Fibrosis Foundation (outside of the submitted work) SB reports grants from the Cystic Fibrosis Foundation (Mental Health Coordinator Award) and the Boomer Esiason Foundation (outside of the submitted work). TS reports grants and personal fees from Alcresta (outside of the submitted work) AF, CB, CR, DG, ED, ET, IN, JA, JZ, LV, PM, RHS, SEH, SGK: Nothing to disclose.

Publication types